Cargando…
Elucidation of the liver pathophysiology of COVID-19 patients using liver-on-a-chips
SARS-CoV-2 induces severe organ damage not only in the lung but also in the liver, heart, kidney, and intestine. It is known that COVID-19 severity correlates with liver dysfunction, but few studies have investigated the liver pathophysiology in COVID-19 patients. Here, we elucidated liver pathophys...
Autores principales: | Deguchi, Sayaka, Kosugi, Kaori, Hashimoto, Rina, Sakamoto, Ayaka, Yamamoto, Masaki, Krol, Rafal P, Gee, Peter, Negoro, Ryosuke, Noda, Takeshi, Yamamoto, Takuya, Torisawa, Yu-suke, Nagao, Miki, Takayama, Kazuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991504/ https://www.ncbi.nlm.nih.gov/pubmed/36896132 http://dx.doi.org/10.1093/pnasnexus/pgad029 |
Ejemplares similares
-
State-of-the-art liver disease research using liver-on-a-chip
por: Deguchi, Sayaka, et al.
Publicado: (2022) -
Editorial for the Special Issue on Organs-on-Chips
por: Torisawa, Yu-suke, et al.
Publicado: (2020) -
Generation of HepG2 Cells with High Expression of Multiple Drug-Metabolizing Enzymes for Drug Discovery Research Using a PITCh System
por: Negoro, Ryosuke, et al.
Publicado: (2022) -
SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expression
por: Hashimoto, Rina, et al.
Publicado: (2022) -
Generation of Tetrafluoroethylene–Propylene
Elastomer-Based Microfluidic Devices for Drug Toxicity and Metabolism
Studies
por: Sano, Emi, et al.
Publicado: (2021)